FMC Corp (FMC) stock saw a modest uptick, ending the day at $65.38 which represents a slight increase of $1.47 or 2.30% from the prior close of $63.91. The stock opened at $64.36 and touched a low of ...

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and ...

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

FMC Corporation FMC is gaining from efforts to expand its product portfolio through new product launches and its restructuring actions. However, it is exposed to pricing and cost headwinds and ...

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

In a report released today, Vincent Andrews from Morgan Stanley maintained a Hold rating on FMC (FMC – Research Report), with a price target of $70.00. The company’s shares closed last Friday ...

New CFO Peter J. Mariani to succeed retiring CFO Kathleen P. BlochOn track for DrugSorb™-ATR U.S. FDA De Novo and Health Canada marketing ...

FMC Corporation FMC will release results for the second quarter of 2024 after the closing bell on Jul 31. The company beat the Zacks Consensus Estimate for earnings in one of the last four ...

The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Please note that the dividend history for Nasdaq stocks ...

Kepler analysts, in their report published on August 1, 2023, also downgraded a Hold rating and set a price target of $19.50 for TechnipFMC PLC’s stock. On Tuesday, TechnipFMC PLC (FTI) stock saw a ...

New CFO Peter J. Mariani to succeed retiring CFO Kathleen P. Bloch On track for DrugSorb™-ATR U.S. FDA De Novo and Health Canada marketing submissions this quarter In Q2 2024, increased product sales ...